Buscador de noticias

E.g., 03/10/2024
E.g., 03/10/2024
Bone marrow contributes to the development of atherosclerosis
Research
21 Mar 2022

The new discovery suggests new research avenues toward the discovery of interventions to prevent or arrest atherosclerosis

Research
17 Mar 2022

The mixing of mitochondrial DNAs (mtDNAs) of two distinct origins can have damaging medium- and long-term effects, according to the results of a new study published in Circulation

. 3D model of a femoral artery obtained by real 3D imaging, revealing the location, number, and extent of distinct atherosclerotic plaques. In this sample, three plaques can be discerned (arrows), at the femoral bifurcation and distributed along the superficial branch.
Research
16 Mar 2022

Scientists at the CNIC have led the development of a new three dimensional ultrasound method that improves the assessment of cardiovascular risk in healthy individuals


La Dra. Karina Yaniv es conocida por sus contribuciones al campo del desarrollo vascular
María García García, Miguel Ángel del Pozo Barriuso, Sara Sánchez Perales, Laura Sotodosos-Alonso, Enrique Calvo, Jesús Vázquez y Asier Echarri
Research
3 Mar 2022

Most biological processes require the import to the cell nucleus of key regulatory factors; one of the most important of these factors is the protein YAP

About the CNIC
27 Jan 2022

Five of the past award winners of this award subsequently received the Nobel Prize

Miguel Palomino Segura, Georgiana Crainiciuc, Jon Sicilia y Andrés Hidalgo
Research
5 Jan 2022

Scientists at the CNIC have developed a simple model for studying the behavior of immune cells in live animals and have identified a harmful cell behavior pattern associated with cardiovascular disease


Alfonso Mora, Ayelén Santamans, Luis Leiva, Guadalupe Sabio, José Antonio Enríquez y Barbara Gonzalez Terán.
Research
24 Nov 2021

The study, published in PLoS Biology, shows for the first time that cardiac metabolism in the postnatal period determines the regulation of metabolism in the whole body

David Sancho y Carlos del Fresno
Research
18 Nov 2021

Immune therapy based on nasal administration of a preparation of dead bacteria called MV130 prevents death in experimental animals infected with the SARS-CoV-2 coronavirus and increases the immunogenicity of COVID-19 vaccines